Dual GLP-1 and Glucagon Receptor Agonism Reduces Energy Intake in People With Type 2 Diabetes With Obesity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity
Diabetes Obes Metab 2024 Apr 01;[EPub Ahead of Print], R Golubic, J Kennet, V Parker, D Robertson, D Luo, L Hansen, L Jermutus, P Ambery, M Ryaboshapkina, M Surakala, RC Laker, M Venables, A Koulman, A Park, M EvansFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.